EANM procedure guidelines for?131I-meta-iodobenzylguanidine (131I-mIBG) therapy?(2008)

The purpose of this guideline is to assist nuclear medicine practitioners to evaluate patients who might be candidates for 131I-meta-iodobenzylguanidine to treat neuro-ectodermal tumours, to provide information for performing this treatment and to understand and evaluate the consequences of therapy.